FDA Inspection
Dr. J Skinclinic, IncDr. J Skinclinic, Inc – FDA Inspection, Mar 17, 2022
Record Details
This FDA Inspection record concerns Dr. J Skinclinic, Inc, with an inspection on March 17, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dr. J Skinclinic, Inc
- Inspection Date
- March 17, 2022
- Product Type
- Drugs
View Company Profile
ID · f6332798-a8bd-4531-9054-be454054fd6a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1164752
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.180(c)Records not made readily available to FDA
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. J Skinclinic, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2026 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for Dr. J Skinclinic, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.